Information on the target
Thann Oryza Co., Ltd., founded in 2003 and headquartered in Bangkok, Thailand, is a premium natural skincare and lifestyle brand. The company has established a strong presence across 14 countries, operating retail stores in key markets such as Thailand, China, Hong Kong, Japan, and Mongolia. In addition to its retail operations, Thann also manages 16 spa facilities throughout the region and a wellness destination located in Ayutthaya, Thailand. The brand is recognized for its commitment to quality and the use of plant-derived ingredients, making it a leader in the aromatherapy and wellness sector.
Industry overview in the target’s specific country
The wellness and spa industry in Thailand has seen significant growth in recent years, driven by increasing consumer awareness of health and wellness. As a result, there is a rising demand for natural and organic products, particularly in skincare and personal care segments. This trend is further supported by the country's rich biodiversity, which provides a wide array of natural ingredients that can be utilized in product development.
Thailand's strategic location in Southeast Asia also positions it as a hub for wellness tourism, attracting both regional and international visitors seeking holistic health experiences. The government has recognized the potential of this sector and is actively promoting wellness tourism as part of its broader economic development strategy. This has led to an influx of investments in wellness-related businesses, including spas, wellness retreats, and natural product brands.
Moreover, the COVID-19 pandemic has accelerated the shift towards wellness and self-care, with consumers increasingly prioritizing their health and well-being. This shift has created opportunities for companies like Thann to expand their offerings and reach new customer segments. As a result, the wellness industry in Thailand is poised for continued growth, making it an attractive market for both domestic and international investors.
The rationale behind the deal
Rohto Pharmaceutical Co., Ltd.'s acquisition of a 51% stake in Thann Oryza Co., Ltd. aligns with the company's strategic expansion into the wellness sector. By partnering with Thann, Rohto aims to leverage the brand's established market presence and expertise in natural skincare to enhance its product portfolio and drive growth in the wellness category. This acquisition not only strengthens Rohto's position in the Asian market but also provides an opportunity to expand Thann's brand globally, capitalizing on the growing demand for wellness products.
Information about the investor Rohto Pharmaceutical Co., Ltd. is a prominent Japanese pharmaceutical and cosmetics company listed on the Tokyo Prime Market (Code: 4527). With a focus on over-the-counter pharmaceuticals, skincare, and food, Rohto operates under its Comprehe…